531 related articles for article (PubMed ID: 21151200)
41. The role of protein kinase C activation in diabetic nephropathy.
Noh H; King GL
Kidney Int Suppl; 2007 Aug; (106):S49-53. PubMed ID: 17653211
[TBL] [Abstract][Full Text] [Related]
42. Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
Zhang X; Zhang J; Ren Y; Sun R; Zhai X
Front Endocrinol (Lausanne); 2024; 15():1368481. PubMed ID: 38455648
[TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update.
Arora MK; Singh UK
Vascul Pharmacol; 2013 Apr; 58(4):259-71. PubMed ID: 23313806
[TBL] [Abstract][Full Text] [Related]
44. Oxidative stress as a major culprit in kidney disease in diabetes.
Forbes JM; Coughlan MT; Cooper ME
Diabetes; 2008 Jun; 57(6):1446-54. PubMed ID: 18511445
[TBL] [Abstract][Full Text] [Related]
45. Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammation.
Olatunji OJ; Chen H; Zhou Y
Biomed Pharmacother; 2018 Jun; 102():1145-1151. PubMed ID: 29710532
[TBL] [Abstract][Full Text] [Related]
46. Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers.
Kushwaha K; Sharma S; Gupta J
Biochimie; 2020 Mar; 170():140-151. PubMed ID: 31954720
[TBL] [Abstract][Full Text] [Related]
47. Advanced glycation endproducts and diabetic nephropathy.
Makita Z; Yanagisawa K; Kuwajima S; Yoshioka N; Atsumi T; Hasunuma Y; Koike T
J Diabetes Complications; 1995; 9(4):265-8. PubMed ID: 8573743
[TBL] [Abstract][Full Text] [Related]
48. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
[TBL] [Abstract][Full Text] [Related]
49. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
Ayodele OE; Alebiosu CO; Salako BL
J Natl Med Assoc; 2004 Nov; 96(11):1445-54. PubMed ID: 15586648
[TBL] [Abstract][Full Text] [Related]
50. Renal endothelial dysfunction in diabetic nephropathy.
Cheng H; Harris RC
Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):22-33. PubMed ID: 24720460
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory cytokines in diabetic nephropathy.
Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
[TBL] [Abstract][Full Text] [Related]
52. Therapies on the Horizon for Diabetic Kidney Disease.
Khan SS; Quaggin SE
Curr Diab Rep; 2015 Dec; 15(12):111. PubMed ID: 26458382
[TBL] [Abstract][Full Text] [Related]
53. Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Liu Y; Li H; Wang S; Yin W; Wang Z
Biomed Pharmacother; 2020 Sep; 129():110321. PubMed ID: 32535382
[TBL] [Abstract][Full Text] [Related]
54. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
55. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
Inagi R; Nangaku M; Miyata T
Ann N Y Acad Sci; 2005 Jun; 1043():605-8. PubMed ID: 16037283
[TBL] [Abstract][Full Text] [Related]
56. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
57. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.
Tabur S; Korkmaz H; Eren MA; Oğuz E; Sabuncu T; Aksoy N
J Diabetes Complications; 2015; 29(1):115-9. PubMed ID: 25179234
[TBL] [Abstract][Full Text] [Related]
58. Hordenine protects against hyperglycemia-associated renal complications in streptozotocin-induced diabetic mice.
Su S; Cao M; Wu G; Long Z; Cheng X; Fan J; Xu Z; Su H; Hao Y; Li G; Peng J; Li S; Wang X
Biomed Pharmacother; 2018 Aug; 104():315-324. PubMed ID: 29775900
[TBL] [Abstract][Full Text] [Related]
59. [Potential therapeutic targets for diabetic nephropathy].
Makino Y; Haneda M
Nihon Rinsho; 2009 Aug; 67(8):1627-35. PubMed ID: 19768953
[TBL] [Abstract][Full Text] [Related]
60. Role of nitric oxide in diabetic nephropathy.
Prabhakar SS
Semin Nephrol; 2004 Jul; 24(4):333-44. PubMed ID: 15252773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
